| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42f352cc5bd193c17ffff15bf60e16f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca36c9afeefbbc24ed8872ddacdb975e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cfc9a97a1c800e47bbd7ddfa40926638
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25a260d3cd0c7f1c73258ae657de6e52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec0024795f45a646ef64b3664ab8a26d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ed25ee9d95ba279ed1c009258e391f2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2012-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c49e8f6d072eb39d1b044022d6624d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d142875a75a1e3a908c42b5c5ee31aae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_715e9012b2fef30236c00cbf4bf20ae9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7eb1770952d32d84380cb0cdeddebf85 |
| publicationDate |
2017-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9678075-B2 |
| titleOfInvention |
Prediction of recurrence for bladder cancer by a protein signature in tissue samples |
| abstract |
The present invention pertains to the field of cancer prediction. Specifically, it relates to a method for predicting the risk of recurrence of bladder cancer in a subject after treatment of bladder cancer comprising the steps of determining the amount of at least one biomarker selected from the biomarkers shown in Table, and comparing the amount of said at least one biomarker with a reference amount for said at least one biomarker, whereby the risk of recurrence of bladder cancer is to be predicted. The present invention also contemplates a method for identifying a subject being in need of a further bladder cancer therapy. Encompassed are, furthermore, diagnostic devices and kits for carrying out said methods. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I664293-B |
| priorityDate |
2011-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |